Our Work

Data Snacks

Press Release — Mar 26, 2025

For Immediate Release

Data Snacks

March 2025

Examining the Effects of Third-Party Lifestyle App Usage Among People With Diabetes

Suggested Articles

Data Snacks

May 1, 2023

Endocrinologist Perspectives: Oral & Injectable Therapies

Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.

Data Snacks

May 1, 2023

Endocrinologist Perspectives: Oral & Injectable Therapies

Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.

Data Snacks

June 25, 2025

Paradigm Shifts in GLP-1 Receptor Agonist Use Amongst Patients with T2 in the USA

About 10% of Americans have Type 2 diabetes (T2), often along with obesity and heart disease.

Data Snacks

June 25, 2025

Paradigm Shifts in GLP-1 Receptor Agonist Use Amongst Patients with T2 in the USA

About 10% of Americans have Type 2 diabetes (T2), often along with obesity and heart disease.

Data Snacks

June 25, 2025

Highlights from ADA 2025: Access dQ&A’s Latest Posters

dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.

Data Snacks

June 25, 2025

Highlights from ADA 2025: Access dQ&A’s Latest Posters

dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.

Our Work

Press Release — Mar 26, 2025

For Immediate Release

Examining the Effects of Third-Party Lifestyle App Usage Among People With Diabetes

Suggested Articles

Where can we take you next?